Page last updated: 2024-08-25

ropivacaine and Lymphoma, T-Cell

ropivacaine has been researched along with Lymphoma, T-Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bauer, I; Braun, S; Fazeli, S; Hermanns, H; Hollmann, MW; Stevens, MF; Werdehausen, R	1

Other Studies

1 other study(ies) available for ropivacaine and Lymphoma, T-Cell

Article	Year
Lipophilicity but not stereospecificity is a major determinant of local anaesthetic-induced cytotoxicity in human T-lymphoma cells. European journal of anaesthesiology, 2012, Volume: 29, Issue:1 Topics: Amides; Anesthetics, Local; Apoptosis; Bupivacaine; Cell Survival; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Inhibitory Concentration 50; Jurkat Cells; Lymphoma, T-Cell; Microscopy, Fluorescence; Necrosis; Ropivacaine; Stereoisomerism; Structure-Activity Relationship	2012

Article

Year

Lipophilicity but not stereospecificity is a major determinant of local anaesthetic-induced cytotoxicity in human T-lymphoma cells.

European journal of anaesthesiology, 2012, Volume: 29, Issue:1

Topics: Amides; Anesthetics, Local; Apoptosis; Bupivacaine; Cell Survival; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Inhibitory Concentration 50; Jurkat Cells; Lymphoma, T-Cell; Microscopy, Fluorescence; Necrosis; Ropivacaine; Stereoisomerism; Structure-Activity Relationship

2012